Therefore,
Thyroid: stop marketing treatment sanofi:
( AFP / LOU BENOIST )
The pharmaceutical giant Sanofi will soon stop marketing a treatment of hypothyroidism which is characterized by an insufficiency of secretion of hormones by the thyroid gland, announced Thursday the National Agency for Medicines (ANSM). However,
The tricolor group informed the ANSM of “the cessation of the marketing of cynomel (sodium Liothyronine)”. Nevertheless, a treatment which concerns around 3,000 patients, “from October 31, 2025”, according to a statement from the health agency which provided a replacement solution. Consequently,
Asked about the reasons for this marketing judgment. Furthermore, the ANSM replied that it followed “a production stop” of cynomel, marketed only in France.
“In 2022, the thyroid: stop marketing treatment sanofi company responsible for the production of cynomel for Sanofi announced its intention to stop this activity. A security stock was produced in order to anticipate the production stop. This stock will provide the French market until October 2025,” Sanofi said to AFP.
“To ensure the continuity of patient treatment”. the laboratory has undertaken to import alternative treatment into France, the Thybon 20 Henning (Liothyronine Chlorhydrate), authorized in Germany for more than 25 years, underlines the ANSM.
According to the press release. these imports will take effect as soon as the cynomel is stopped and will be followed by a marketing authorization request for Thybon, in order to “ensure lasting access to this medication” and “to prevent patients with repeated drug changes”.
“There will thus be no supply of supply between the end of Cynomel distribution. the start of the provision of Thybon,” says the thyroid: stop marketing treatment sanofi ANSM.
The two drugs have the same basic molecule (Lithyronine) but different excipients.
thyroid: stop marketing treatment sanofi — Thyroid: stop marketing treatment sanofi: ( AFP / LOU BENOIST ). The pharmaceutical giant Sanofi will soon stop marketing a treatment of hypothyroidism which is char.
Further reading: In Bastia, the hospital adopts emergency regulation in the face of the double summer and internal pressure – Alberta exceeds the United States with more than 1,300 cases of confirmed measles – Low background: revised and improved care algorithm for doctors – Mosquito struggle: less widespread larvicide thanks to drones – This silent sign, present in 62 % of cases.
 The pharmaceutical giant Sanofi will…){kind=link}